CAS 610318-54-2

RGX-104 free Acid 

CAS : 610318-54-2

Formule : C₃₄H₃₃ClF₃NO₃

Degré de pureté : 98%

Couleur et forme : Solid

Masse moléculaire : 596.0789

Ref: IN-DA01EOEC

(R)-2-(3-(3-((2-Chloro-3-(Trifluoromethyl)Benzyl)(2,2-Diphenylethyl)Amino)Butoxy)Phenyl)Acetic Acid

CAS : 610318-54-2

(R)-2-(3-(3-((2-Chloro-3-(Trifluoromethyl)Benzyl)(2,2-Diphenylethyl)Amino)Butoxy)Phenyl)Acetic Acid

Degré de pureté : 98%

Masse moléculaire : 596.08g/mol

Ref: 54-PC108381

RGX-104

CAS : 610318-54-2

RGX-104

Degré de pureté : ≥98%

Masse moléculaire : 596.08g/mol

Ref: 54-BUP09170

RGX-104

CAS : 610318-54-2

RGX-104 (RGX-104 free Acid) free Acid is an agonist of potent liver-X nuclear hormone receptor (LXR)

Formule : C₃₄H₃₃ClF₃NO₃

Degré de pureté : 98.79% - 99.53%

Couleur et forme : Solid

Masse moléculaire : 596.08

Ref: TM-T7768

RGX-104 free Acid

CAS : 610318-54-2

RGX-104 is a synthetic molecule that can modulate the activity of ABCA1 and is currently being studied for its potential to treat cancer. It has been shown to reduce cholesterol synthesis in cells by interfering with the activation of sterol regulatory element binding protein-1 (SREBP-1) and thereby inhibiting transcriptional regulation. RGX-104 also has anticancer properties, as it inhibits cellular proliferation and resistance in cancer cells. Studies show that RGX-104 decreases tumor growth, induces apoptosis, and inhibits angiogenesis in some cancers. It also shows promise for the treatment of bladder cancer

Formule : C₃₄H₃₃ClF₃NO₃

Degré de pureté : Min. 95%

Masse moléculaire : 596.08 g/mol

Ref: 3D-KZA31854